Filing Details

Accession Number:
0000899243-16-017929
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-11 17:47:38
Reporting Period:
2016-04-07
Filing Date:
2016-04-11
Accepted Time:
2016-04-11 17:47:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609809 Seres Therapeutics Inc. MCRB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1233684 N David Cook C/o Seres Therapeutics, Inc.
215 First Street
Cambridge MA 02142
Chief Scientific Officer & Evp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-04-07 8,000 $31.00 160,673 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2016.